Showing results (321-330 of 335) with videos related to
Sort By:
Pageof 34
Free Radical Biology & Medicine|November 17, 2009
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitisSudhir Chowdhry, Maiiada H Nazmy, Paul J Meakin, et al.Journal of Clinical Pathology|July 6, 2014
RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics GroupNewton A C S Wong, David Gonzalez, Manuel Salto-Tellez, et al.The American Journal of Physiology|September 1, 1987
Isolated muscle cells as a physiological modelM Lieberman, S D Hauschka, Z W Hall, et al.Prehospital Emergency Care|June 4, 2025
Frequency and Factors Associated with Patient Safety Events During Prehospital Obstetric EmergenciesRebecca E Cash, Maeve F Swanton, Melissa A Meeker, et al.Human Genetics|May 1, 1991
The physical map of chromosome arm 19q: some new assignments, confirmations and re-assessmentsJ D Brook, S J Knight, S H Roberts, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2004
Ca2+ syntillas, miniature Ca2+ release events in terminals of hypothalamic neurons, are increased in frequency by depolarization in the absence of Ca2+ influxValérie De Crescenzo, Ronghua ZhuGe, Cristina Velázquez-Marrero, et al.Molecular and Cellular Biology|June 25, 2014
Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistancePaul J Meakin, Sudhir Chowdhry, Ritu S Sharma, et al.Journal of Alzheimer'S Disease : JAD|February 13, 2021
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's DiseaseTimothy M Shoup, Ana Griciuc, Marc D Normandin, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|January 14, 2012
Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrierRachel V Bowie, Simona Donatello, Clíona Lyes, et al.Gastrointestinal Cancer Research : GCR|December 7, 2013
A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic AdenocarcinomaVolkan Cetin, Bilal Piperdi, Venu Bathini, et al.Pageof 34